A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415)
Maluf, Fernando C., Schutz, Fabio A., Cronemberger, Eduardo H., Luz, Murilo de A., Martins, Suelen P.S., Muniz, David Q.B., Bastos, Diogo A., Cárcano, Flavio M., Smaletz, Oren, Soares, Andrey, Peixoto, Fábio A., Gomes, Andrea J., Cruz, Felipe M., Franke, Fabio A., Herchenhorn, Daniel, dos Santos, Telma M., Fabricio, Vanessa de C., Gidekel, Rosemarie, Werutsky, Gustavo, de Jesus, Rafaela G., Souza, Vinicius C., Fay, André P.
Published in European journal of cancer (1990) (01.11.2021)
Published in European journal of cancer (1990) (01.11.2021)
Get full text
Journal Article
Survival analysis of the randomized phase II trial to investigate androgen signaling inhibitors with or without androgen deprivation therapy (ADT) for castration-sensitive prostate cancer: LACOG 0415
Maluf, Fernando Cotait, Soares, Andrey, Bastos, Diogo Assed, Schutz, Fabio A. B., Cronemberger, Eduardo, Luz, Murilo, Martins, Suelen P. S., Muniz, David Queiroz Borges, Carcano, Flavio Mavignier, Smaletz, Oren, Peixoto, Fábio A, Gomes, Andrea J, Cruz, Felipe Melo, Franke, Fabio, Herchenhorn, Daniel, Gidekel, Rosemarie, Rebelatto, Taiane Francieli, Gomes, Rafaela, Souza, Vinicius Carrera, Fay, Andre P.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Survival outcomes of metastatic castration-resistant prostate cancer in Brazil (LACOG 1818)
Maluf, Fernando Cotait, Martins, Suelen P. S., Silva Neto, Deusdedit Cortêz Vieira, Werutsky, Gustavo, Rinck Jr, Jose Augusto, Bastos, Diogo Assed, Rocha, Roberto Odebrecht, Fay, Andre P., Fernandes, Roni de Carvalho, Girardi, Daniel da Motta, Araujo, Daniel Vilarim, Mota, Augusto C. A., Lara Gongora, Aline Bobato, Fernandes, Bruno Melo, Alves, Ana Caroline Fonseca, Sampaio, Cristina de Deus Anjos Tavares, de Souza, Andréa Lopes Ponte, de Jesus, Rafaela Gomes, Gössling, Gustavo Cartaxo de Lima, Soares, Andrey
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
Health-related quality-of-life (HRQoL) analysis from a randomized phase II trial of androgen signaling inhibitors with or without androgen deprivation therapy (ADT) for castration-sensitive prostate cancer: LACOG 0415
Soares, Andrey, Bastos, Diogo Assed, Schutz, Fabio A. B., Cronemberger, Eduardo, Luz, Murilo, Martins, Suelen P. S., Muniz, David Queiroz Borges, Carcano, Flavio Mavignier, Smaletz, Oren, Peixoto, Fábio A, Gomes, Andrea Juliana, Cruz, Felipe Melo, Franke, Fabio Andre, Herchenhorn, Daniel, Gidekel, Rosemarie, Rebelatto, Taiane Francieli, Gomes, Rafaela, Souza, Vinicius Carrera, Fay, Andre P., Maluf, Fernando C.
Published in Journal of clinical oncology (20.02.2021)
Published in Journal of clinical oncology (20.02.2021)
Get full text
Journal Article
Phase II randomized study of abiraterone acetate plus prednisone (AAP) added to ADT versus apalutamide alone (APA) versus AAP+APA in patients with advanced prostate cancer with noncastrate testosterone levels: (LACOG 0415)
Maluf, Fernando C., Fay, Andre P., Souza, Vinícius Carrera, Schutz, Fabio A. B., Smaletz, Oren, Herchenhorn, Daniel, Fabricio, Vanessa, Gidekel, Rosemarie, Cronemberger, Eduardo, Luz, Murilo, Martins, Suelen P. S., Muniz, David Queiroz Borges, Franke, Fabio Andre, Peixoto, Fabio, Carcano, Flavio Mavignier, Gomes, Andrea Juliana, Cruz, Felipe, Gomes, Rafaela, Nunes Filho, Paulo Ricardo Santos, Werutsky, Gustavo
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article